Who are Atracurium's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Tracrium Preservative Free.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/atracurium-besylate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Atracurium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Atracurium (Atracurium Besylate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nondepolarizing skeletal muscle relaxant. Area: Neuroscience.

marketed Nondepolarizing skeletal muscle relaxant Cholinergic receptor sites on motor end-plate Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Atracurium (Atracurium Besylate) — Pfizer. Nondepolarizing skeletal muscle relaxant that competitively antagonizes acetylcholine at motor end-plate cholinergic receptors.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Atracurium TARGET	Atracurium Besylate	Pfizer	marketed	Nondepolarizing skeletal muscle relaxant	Cholinergic receptor sites on motor end-plate	1983-01-01
Tracrium Preservative Free	Atracurium Besylate	Pfizer Inc.	marketed	Nondepolarizing neuromuscular blocking agent	Cholinergic receptor sites on motor end-plate	1983-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nondepolarizing skeletal muscle relaxant class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Atracurium — Competitive Intelligence Brief. https://druglandscape.com/ci/atracurium-besylate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab